Published on 21/12/2025
“Understanding the Requirements of ICH-GCP E6(R2)”
ICH-GCP E6(R2) Requirements: An Overview
The International Council for Harmonisation – Good Clinical Practice (ICH-GCP) E6(R2) is a global standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. It seeks to ensure the protection of human subjects and the credibility of clinical trial data. This article provides a comprehensive overview of the ICH-GCP E6(R2) requirements.
Principles of ICH-GCP
ICH-GCP guidelines are grounded in a set of core principles, including the ethical conduct of clinical trials, ensuring the rights and well-being of trial subjects, and the provision of credible data. Other principles include the requirement that a clinical trial be scientifically sound and described in a clear detailed protocol. Moreover, the benefits must outweigh the risks, and informed consent from trial subjects is a must.
Investigator’s Responsibility
Investigators play a central role in ICH-GCP. They are responsible for ensuring the trial’s conduct and the rights, safety, and well-being of trial subjects are protected. Investigators must also ensure the data reported is accurate, complete, and verifiable from source documents. Training in GMP can help investigators understand the importance of maintaining high-quality data
Sponsor’s Responsibility
Sponsors are responsible for implementing and maintaining quality assurance and quality control systems. They must also ensure data management and record keeping is compliant with ICH-GCP requirements. Sponsors are also responsible for forced degradation studies and shelf life prediction, which are crucial for the safety and efficacy of the investigational product.
Essential Documents
ICH-GCP E6(R2) stipulates the essential documents to be maintained before, during, and after the conduct of a clinical trial. These documents serve to demonstrate the compliance of the investigator, sponsor, and monitor with the standards of GCP and with the regulatory requirements. Essential documents also serve a practical purpose, as they guide the conduct of the clinical trial and confirm that it was conducted appropriately. These documents include protocols, Investigator’s Brochures, consent forms, and others. SOP writing in pharma and Pharmaceutical SOP examples can help in preparing these documents.
Quality Management
Quality Management is a critical part of ICH-GCP E6(R2). Sponsors are expected to implement a system for managing quality throughout all stages of the trial process, focusing on trial activities essential to ensuring human subject protection and the reliability of trial results. This includes equipment qualification in pharmaceuticals to ensure the equipment used in the trial is suitable for its intended purpose.
Regulatory Requirements
The ICH-GCP E6(R2) also details the regulatory requirements for conducting clinical trials. These include obtaining the necessary permissions from regulatory authorities before starting the trial, reporting progress and safety issues promptly, and complying with inspection requirements. Understanding regulatory compliance in the pharmaceutical industry is crucial for investigators and sponsors to ensure adherence to these requirements. For more information about the specific requirements in Brazil, refer to the guidelines provided by ANVISA.
In conclusion, the ICH-GCP E6(R2) serves as a comprehensive guide for the conduct of clinical trials, ensuring they are scientifically sound, ethical, and that the rights, safety, and well-being of trial subjects are protected. It is imperative for all involved in clinical trials to understand and adhere to these guidelines.